Clinical trial
Comparison of Antibody Levels in Children and Adolescents After Initiation of…
NCT00410033 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00410033 |
|---|---|
| Title | Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin |
| Official title | Safety/Efficacy Trial Using Stored Serum Samples to Investigate the Immunogenicity of Insulin Aspart and Soluble Human Insulin in Children and Adolescents From Onset of Type 1 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | soluble human insulin, isophane human insulin, insulin aspart |
| Enrollment | 74 |
| Start date | Dec 1, 1989 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Dec 12, 2006 |
| Last update posted | Dec 22, 2016 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: